Prostate-specific membrane antigen is undetectable in choroidal neovascular membrane

Journal of Carcinogenesis

Volumn 5, Issue , 2006, Pages

  Godeiro, Katyanne Dantas ^a,b   de Arantes Frota, Ana Carolina ^a,b   Antecka, Emilia ^a   Odashiro, Alexandre Nakao ^a,b   Maloney, Shawn ^a   Fernandes, Bruno ^a   Burnier Jr , Miguel Noel ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BLOOD CLOTTING FACTOR 8; PROSTATE SPECIFIC MEMBRANE ANTIGEN;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TUMOR VASCULARIZATION;

EID: 33748712082     PISSN: 14773163     EISSN: 14773163     Source Type: Journal    
DOI: 10.1186/1477-3163-5-21     Document Type: Article

References (19)

1. Cruickshanks KJ, Hamman RF, Klein R, Nondahl DM, Shetterly SM: The prevalence of age-related maculopathy by geographic region and ethnicity. The Colorado-Wisconsin Study of Age-Related Maculopathy. Arch Ophthalmol 1997, 115:242-250.
2. Klein R, Klein BE, Linton KL: Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992, 99:933-943.
3. Maberley DA, Hollands H, Chuo J, Tam G, Konkal J, Roesch M, Veselinovic A, Witzigmann M, Bassett K: The prevalence of low vision and blindness in Canada. Eye 2006, 20:341-346.
4. Mitchell P, Smith W, Attebo K, Wang JJ: Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995, 102:1450-1460.
5. Oshima Y, Ishibashi T, Murata T, Tahara Y, Kiyohara Y, Kubota T: Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study. Br J Ophthalmol 2001, 85:1153-1157.
6. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP: Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003, 48:257-293.
7. Grossniklaus HE, Green WR: Choroidal neovascularization. Am J Ophthalmol 2004, 137:496-503.
8. Heriot WJ, Henkind P, Bellhorn RW, Burns MS: Choroidal neovascularization can digest Bruch's membrane. A prior break is not essential. Ophthalmology 1984, 91:1603-1608.
9. Horoszewicz JS, Kawinski E, Murphy GP: Monoclonal antibodies to a new antigenic marker in epithellial prostatic cells and serum of prostatic cancer patients. Anticancer Res 1987, 7:927-935.
10. Israeli RS, Powell CT, Fair WR, Heston WD: Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 1993, 53:227-230.
11. Carter RE, Feldman AR, Coyle JT: Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc Natl Acad Sci U S A 1996, 93:749-753.
12. Pinto JT, Suffoletto BP, Berzin TM, Qiao CH, Lin S, Tong WP, May F, Mukherjee B, Heston WD: Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells. Clin Cancer Res 1996, 2:1445-1451.
13. Lopes AD, Davis WL, Rosenstraus MJ, Uveges AJ, Gilman SC: Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5. Cancer Res 1990, 50:6423-6429.
14. Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C: Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res 1997, 3:81-85.
15. Liu H, Moy P, Kim S, Xia Y, Rajasekaran A, Navarro V, Knudsen B, Bander NH: Monoclonal antibodies to the extracellullar domain of prostate-specific membrane antigen also react with tumor vascular endothelium. Cancer Res 1997, 57:3629-3634.
16. Grossniklaus HE, Ling JX, Wallace TM, Dithmar S, Lawson DH, Cohen C, Elner VM, Elner SG, Sternberg PJ: Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis 2002, 8:119-126.
17. Chang SS, Reuter VE, Heston WD, Gaudin PB: Comparison of antiprostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma. Urology 2001, 57:1179-1183.
18. Chang SS, O'Keefe IDS, Bacich DJ, Reuter VE, Heston WD, Gaudin PB: Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin Cancer Res 1999, 5:2674-2681.
19. Chang SS, Reuter VE, Heston WD, Bander NH, Grauer LS, Gaudin PB: Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res 1999, 59:3192-3198.